Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

NIH gambles on recycled drugs

Nature volume 499, pages 263–264 (2013)Cite this article

Subjects

Early success could bolster congressional support for agency’s translational science centre.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Authors
  1. Meredith Wadman
    View author publications

    Search author on:PubMed Google Scholar

Related links

Related links

Related links in Nature Research

Translational research: Medicine man 2013-Feb-06

New cures sought from old drugs 2012-Oct-03

National prescription for drug development 2012-Apr-10

Blogpost: NIH funds effort to resurrect abandoned drugs for new uses

Blogpost: MRC awards drug resurrection grants

Related external links

NCATS awards for drug repurposing

MRC–AstraZeneca awards for drug repurposing

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wadman, M. NIH gambles on recycled drugs. Nature 499, 263–264 (2013). https://doi.org/10.1038/499263a

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/499263a

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research